MedTrace Logo

Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care

NCT01983813 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 302

Last updated 2019-08-13

No results posted yet for this study

Summary

The trial will examine whether a centralized Prevention Health \& Cardiovascular Risk Service (PHCVRS) run by clinical pharmacists at the University of Iowa can be implemented in primary care offices and whether it can improve the care delivered to patients at risk for developing cardiovascular disease.

Conditions

Interventions

OTHER

PHCVRS Intervention

A clinical pharmacist at the PHCVRS will follow each participant in the PHCVRS arm for 12 months, including: 1. Contact via email, phone or text every 2-4 weeks 2. Assessment and counseling for medication adherence, side effects, and lifestyle modifications to decrease risk of cardiovascular disease. 3. Collaborative communication with the participant's physician to address gaps in screening or therapy, update medication list, and recommend medication changes. Each participant in this arm will also have access to an online Personal Health Record that can be used to track medications, diagnosed conditions and laboratory values related to cardiovascular disease risk.

OTHER

Personal Health Record

Participant will be able to access an online Personal Health Record for tracking medications and diagnosed conditions

Sponsors & Collaborators

  • Korey Kennelty

    lead OTHER

Principal Investigators

  • Barry L. Carter, Pharm.D. · University of Iowa

  • Barcey T. Levy, M.D., Ph.D. · University of Iowa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-19
Primary Completion
2016-11-30
Completion
2018-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01983813 on ClinicalTrials.gov